SDRC investigators find evidence in CREDENCE clinical trial for efficacy and safety of canagliflozin for type2 diabetes

Written by Yong Chong

https://medicine.stanford.edu/2020-report/credence-brings-together.html

Yong Chong
Previous

SDRC investigators team up to create a new device that can perform blood tests continually
Next

Carolyn Bertozzi named Baker Family Director of Stanford ChEM-H